<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">515</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.3.121-126</article-id>
<title-group><article-title>A Comparative Study on the Efficacy and Safety of Autologous Serum Therapy versus Azathioprine in the Treatment of Chronic Spontaneous Urticaria at a Tertiary Healthcare Centre in Uttar Pradesh</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Cherishma</surname><given-names>Gavvala</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Saxena</surname><given-names>Deepti</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Sundiep</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Dr.Rishabh Raj</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Danish</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="aff4"/></contrib>
<aff id="aff1"><label>1</label>Post Graduate Resident (3rd Year), Department of Dermatology, Venereology and Leprology, Saraswathi Institute of Medical Sciences, Hapur, Uttar Pradesh, India</aff>
<aff id="aff2"><label>2</label>Professor &amp; Head, Department of Dermatology, Venereology and Leprology, Saraswathi Institute of Medical Sciences, Hapur, Uttar Pradesh, India</aff>
<aff id="aff3"><label>3</label>Professor, Department of Dermatology, Venereology and Leprology, Saraswathi Institute of Medical Sciences, Hapur, Uttar Pradesh, India</aff>
<aff id="aff4"><label>4</label>Assistant Professor, Department of Dermatology, Venereology and Leprology, Saraswathi Institute of Medical Sciences, Hapur, Uttar Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>23</day><month>07</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>3</issue>
<fpage>121</fpage>
<lpage>126</lpage>
<history>
<date date-type="received"><day>26</day><month>05</month><year>2026</year></date>
<date date-type="accepted"><day>24</day><month>06</month><year>2026</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/515/a-comparative-study-on-the-efficacy-and-safety-of-autologous-serum-therapy-versus-azathioprine-in"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/515/download"/>
<abstract><p>Background: Chronic spontaneous urticaria (CSU) is a common inflammatory dermatosis characterised by recurrent wheals, pruritus, and angioedema persisting for six weeks or longer without an identifiable trigger. A substantial proportion of patients remain symptomatic despite standard antihistamine therapy, necessitating immunomodulatory alternatives such as autologous serum therapy (AST) and azathioprine.
Objective: To compare the efficacy and safety of AST and azathioprine in patients with CSU attending a tertiary healthcare centre in Uttar Pradesh.
Methods: In this prospective, interventional study, 60 patients with CSU aged 18–60 years were randomly allocated to two groups of 30. Group A received weekly intramuscular autologous serum injections for 9 weeks; Group B received oral azathioprine 50 mg/day for 12 weeks. Disease severity was quantified using the Total Severity Score (TSS) at baseline and at 4, 8, and 12 weeks. Clinical response, autologous serum skin test (ASST) status, antihistamine requirement, and adverse events were recorded.
Results: Baseline characteristics were comparable between groups (p &gt; 0.05). Mean TSS fell from 13.3 ± 2.1 to 5.6 ± 1.8 in the AST group (57.8% reduction) and from 14.2 ± 1.9 to 3.4 ± 1.6 in the azathioprine group (76.1% reduction) at 12 weeks (p &lt; 0.001). Total response rate was 73.3% with AST versus 83.4% with azathioprine, with complete remission in 23.3% and 46.7% of patients respectively (p = 0.038). ASST-positive status, shorter disease duration, absence of angioedema, younger age, and female sex were associated with better outcomes. Both therapies were well tolerated; no serious adverse events or treatment discontinuations occurred.
Conclusion: Azathioprine produced faster and more complete symptom control, whereas AST offered a safe, low-cost, minimally invasive alternative with a simpler monitoring burden. Treatment selection in CSU should be individualised according to disease severity, ASST status, comorbidity, and resource availability.
 </p></abstract>
<kwd-group kwd-group-type="author"><kwd>Chronic spontaneous urticaria</kwd><kwd>Autologous serum therapy</kwd><kwd>Azathioprine</kwd><kwd>Total severity score</kwd><kwd>Autologous serum skin test</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol. 2017;139(6):1772-81.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola CP, Agostinis F, et al. Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol. 2013;93:268-72.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Ben-Shoshan M, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy. 2013;68(2):131-41.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Kaplan A, Lebwohl M, Giménez-Arnau AM, Hide M, Armstrong AW, Maurer M. Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances. Allergy. 2023;78(2):389-401.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am. 2014;34(1):33-52.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Saini SS, Asero R, Cugno M, Park HS, Oliver ET. Pathogenesis of chronic spontaneous urticaria with or without angioedema. J Allergy Clin Immunol Pract. 2025;13(9):2221-8.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226-36.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Soong W, Patil D, Rodrigues J, Kohli RK, Krupsky K, Gupta S, et al. Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States. World Allergy Organ J. 2025;18(8):101081.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77:734-66.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Riedl MA, Patil D, Rodrigues J, Kuruvilla M, Raftery T, International Journal of Medical and All Body Health Research www.allmedicaljournal.com Pivneva I, et al. Clinical burden, treatment, and disease control in patients with chronic spontaneous urticaria: real-world evidence. Ann Allergy Asthma Immunol. 2025;134(3):324-32.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Johal KJ, Saini SS. Current and emerging treatments for chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2020;125(4):380-7.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol. 2008;74(2):109-13.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Yu L, Buttgereit T, Stahl Skov P, Schmetzer O, Scheffel J, Kocatürk E, et al. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2019;33(9):1747-54.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Godse KV, Nadkarni N, Patil S, Mehta A. Subcutaneous autologous serum therapy in chronic spontaneous urticaria. Indian J Dermatol. 2017;62(5):505-7.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CEH. EAACI/GA²LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64:1256-68.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Baumann K, Marcelino J, Skov PS, Santos MC, Wyroslak I, Scheffel J, et al. Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions. J Eur Acad Dermatol Venereol. 2021;35(6):1338-45.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Kumar YH, Bhaskar S, Shankar K. Comparative study of positive versus negative autologous serum skin test in chronic spontaneous urticaria and its treatment outcome. North Am J Med Sci. 2016;8(1):25.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Kocatürk E, Aktaş S, Türkoğlu Z, Kavala M, Zindancı I, Koç M, et al. Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo-controlled, randomized, single-blind study. J Dermatolog Treat. 2012;23(6):465-71.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Bhanja DC, Ghoshal L, Das S, Das S, Roy AK. Azathioprine in autologous serum skin test positive chronic urticaria: a case-control study in a tertiary care hospital of eastern India. Indian Dermatol Online J. 2015;6(3):185-8.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Tal Y, Toker O, Agmon-Levin N, Shalit M. Azathioprine as a therapeutic alternative for refractory chronic urticaria. Int J Dermatol. 2015;54(3):367-9.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Elazab S, Hessam W. The effect of autologous serum therapy in chronic spontaneous urticaria depends on autologous serum skin test positivity. Egypt J Immunol. 2017;24(2):165-72.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Valapil AP, Issac CM, Vineetha M. Autologous serum therapy in chronic idiopathic urticaria. J Evid Based Med Healthc. 2020;7(30):1453-8.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Wannous BI, Khaddam J, Ismaiel MA. Efficacy of autologous serum therapy in chronic urticaria: a prospective experimental cohort study. Open Dermatol J. 2022;16:e2209260.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Mohammed J. Autologous serum therapy reduces the symptoms and antihistamine burden in patients with chronic urticaria. Adv Dermatol Allergol. 2023;40:398-401.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Chu A, Oykhman P, Chu X, Rayner D, Bhangal S, Dam A, et al. Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: systematic review and network meta-analysis. J Allergy Clin Immunol. 2025;156(4):1008-23.</mixed-citation></ref>
</ref-list></back>
</article>